OSPIMA Trademark

Trademark Overview

On Tuesday, April 10, 2007, a trademark application was filed for OSPIMA with the United States Patent and Trademark Office. The USPTO has given the OSPIMA trademark a serial number of 77152595. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 7, 2011. This trademark is owned by Amgen Inc.. The OSPIMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of bone disease
ospima

General Information

Serial Number77152595
Word MarkOSPIMA
Filing DateTuesday, April 10, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 7, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 16, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of bone disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 13, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201789

Trademark Events

Event DateEvent Description
Monday, February 7, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 7, 2011ABANDONMENT - NO USE STATEMENT FILED
Saturday, May 29, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 28, 2010EXTENSION 5 GRANTED
Tuesday, May 25, 2010EXTENSION 5 FILED
Tuesday, May 25, 2010TEAS EXTENSION RECEIVED
Thursday, December 3, 2009EXTENSION 4 GRANTED
Monday, November 30, 2009EXTENSION 4 FILED
Monday, November 30, 2009TEAS EXTENSION RECEIVED
Tuesday, May 26, 2009EXTENSION 3 GRANTED
Friday, May 22, 2009EXTENSION 3 FILED
Friday, May 22, 2009TEAS EXTENSION RECEIVED
Thursday, November 13, 2008EXTENSION 2 GRANTED
Tuesday, November 11, 2008EXTENSION 2 FILED
Thursday, November 13, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 11, 2008TEAS EXTENSION RECEIVED
Thursday, June 5, 2008EXTENSION 1 GRANTED
Thursday, May 22, 2008EXTENSION 1 FILED
Thursday, May 22, 2008TEAS EXTENSION RECEIVED
Tuesday, January 8, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 16, 2007PUBLISHED FOR OPPOSITION
Wednesday, September 26, 2007NOTICE OF PUBLICATION
Tuesday, September 11, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 11, 2007ASSIGNED TO LIE
Friday, August 3, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 3, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 3, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 3, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 27, 2007NON-FINAL ACTION E-MAILED
Friday, April 27, 2007NON-FINAL ACTION WRITTEN
Tuesday, April 24, 2007ASSIGNED TO EXAMINER
Friday, April 13, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

ospima disease bone treatment preparations pharmaceutical